Judgment of the Amsterdam Court of Appeal in the criminal case public prosecutor/ members of the Santo Daime church Amsterdam.   Dear friends, It is with great...

The United Nations has played a significant historical role in the control of psychedelic drugs worldwide. 2023's World Drug Report marks a renewed interest in psychotropic substances on the part of the international governing body.

What began as a casual conversation between two friends last summer has now developed into an unstoppable global healing movement. David Grillot and Jonathan Glazer realised the importance...

The Chacruna Institute endorses the Breakthrough Therapies Act introduced by Senators Cory Booker and Rand Paul. Chacruna supports this opportunity to reduce barriers to MDMA and psilocybin-assisted therapy.

  Where to start? From February 28 forward, our religion is illegal in our country. For 23 years we have been in communication with “the law”; and,...

The Chacruna Institute and Sacred Plant Alliance filed this amicus brief on October 17, 2023 in support of the plaintiff church in the Iowaska Church of Healing v. United States case, to emphasize to the U.S. Court of Appeals for the D.C. Circuit why the decision in the lower court, the district court, was wrongly decided.

Dear friends and colleagues, I am asking for help, urgently, with this letter. It has three parts: (1) background, (2) donation links, (3) petition links. Read all, or jump...

WHO WE ARE: The Chacruna Institute for Psychedelic Plant Medicines, is a 501(c)(3) non-profit organization co-founded by Brazilian anthropologist Dr. Bia Labate and American psychologist...

  Are you or is someone you know looking for research funding? We are a private non-profit foundation. Our mission is to connect, inspire, and support...

In this article, Marcelo Leite outlines the major developments in psychedelic science and markets going into 2024 that are causing industry trepidation. The biggest news of January comes from MAPS and its business division, which has been rebranded as Lykos Therapeutics.